Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 15;219(5):703-710.
doi: 10.1093/infdis/jiy533.

Genital Wart Recurrence Among Men Residing in Brazil, Mexico, and the United States

Affiliations

Genital Wart Recurrence Among Men Residing in Brazil, Mexico, and the United States

Anna R Giuliano et al. J Infect Dis. .

Abstract

Background: Genital wart (GW) incidence is high among men. The percentage and rate at which subsequent GW events occur are understudied. The purpose of this study was to describe the rate of subsequent GWs, associated human papillomavirus (HPV) types, and time to subsequent GW event among unvaccinated men.

Methods: The study was nested within a multinational prospective HPV natural history study of men aged 18-70 years in the United States, Mexico, and Brazil, examined every 6 months for a median follow-up of 50.4 months. Subsequent GW events were defined as GWs detected after ≥16 weeks of the prior event.

Results: Forty-four percent of men experienced ≥1 GW following the initial episode. Men with ≥2 subsequent events were at highest risk of continued GW experiences, with as high as 10 postinitial GW events. The incidence rate of each subsequent GW increased with increasing events (incidence of first subsequent event was 13.1 vs 36.6/1000 person-months for the fourth event). The proportion of GWs among HPV-6 and/or -11-positive patients remained constant across events. Approximately 63%-69% were positive for ≥1 of the 9-valent HPV vaccine types.

Conclusions: These data highlight the high burden of GWs among men across the lifespan and the need for vaccination to prevent multiple GW episodes.

Keywords: HPV; genital warts; vaccination.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Kaplan–Meier survival estimates. A, Time to first subsequent genital wart occurrence. B, Time to first subsequent genital wart occurrence, stratified by country.
Figure 2.
Figure 2.
Proportion of men with subsequent genital warts stratified by type of event (recurrent vs new genital wart).

Comment in

References

    1. de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13:607–15. - PubMed
    1. World Health Organization. Global strategy for the prevention and control of sexually transmitted infections (2006–2015). Geneva, Switzerland: WHO, 2007.
    1. Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine 2012; 30(Suppl 5):F12–23. - PubMed
    1. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006; 24(Suppl 3):S3/35–41. - PubMed
    1. Anic GM, Lee JH, Villa LL, et al. Risk factors for incident condyloma in a multinational cohort of men: the HIM study. J Infect Dis 2012; 205:789–93. - PMC - PubMed

Publication types